Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2023-01-24 00:00:00 ET · period of report 2023-01-20 · accession 0001127602-23-002139 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-24 | 2023-01-20+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $1.71 | -296.0K | 15.36M | -2% | -$505.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-01-20 | S | D | 152,205 | $1.67 | 15,503,589 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-01-23 | S | D | 143,807 | $1.75 | 15,359,782 | D | — | — |